RxDoctor Payments Data

Daniel Jondle, MD

Anatomic Pathology & Clinical Pathology · Phoenix, AZNPI 1649255449

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $270 of the $350 with a category attached, or 77.2%. Biomerieux Inc accounts for 77.2% of it on its own, with 3 other manufacturers making up the rest. 2022 is the largest year on record at $270, 7.3 times the $37 reported in 2019.

$350in general payments, 2019–2025

Across 4 payments — averaging $87.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biomerieux Inc$270
  • UCB, Inc.$37
  • Meridian Bioscience Inc.$28
  • Intercept Pharmaceuticals, Inc.$14

What the payments were for

  • Consulting fees$27077%
  • Food & beverage$8023%

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$350 in reported general payments places this provider in the 70th percentile of 153 anatomic pathology & clinical pathology providers in Arizona.

See all anatomic pathology & clinical pathology providers in Arizona

Medicare billing

Part B allowed, 2024
$581,597
Medicare patients
3,529
Services billed
8,358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →